HONG KONG, March 16, 2018 /PRNewswire/ -- China Cord
Blood Corporation (NYSE: CO) ("CCBC" or the "Company"), a
leading cord blood banking operator in China, today announced the results of its
extraordinary general meeting of shareholders, which was held on
March 16, 2018, in Hong Kong S.A.R.,
China (the "Extraordinary General
Meeting").
At the Extraordinary General Meeting, shareholders approved the
Company's name to change from "China Cord Blood Corporation" to
"Global Cord Blood Corporation" ("GCBC" or the "New Name"). The
Company expects to receive approval from the Registrar of Companies
in the Cayman Islands for the name
change in the next several days and that GCBC's ordinary shares
will commence trading under the New Name on the New York Stock
Exchange with effect from March 22,
2018 under a new CUSIP of G39342 103 and ISIN of
KYG393421030 but still with ticker symbol "CO". The website address
of the Company will be changed to
http://www.globalcordbloodcorp.com.
The change of Company name will not affect any of the rights of
the existing shareholders of the Company. All share certificates of
the Company in issue bearing the former name of the Company
continue to be evidence of title and valid for all purposes
(including for the purposes of trading, settlement, registration
and delivery). New share certificates of the Company which are
issued on or after March 22, 2018
will be issued under the New Name of the Company.
About China Cord Blood Corporation
China Cord Blood Corporation is the first and largest umbilical
cord blood banking operator in China in terms of geographical coverage and
the only cord blood banking operator with multiple licenses. Under
current PRC government regulations, only one licensed cord blood
banking operator is permitted to operate in each licensed region
and no new licenses will be granted before 2020 in addition to the
seven licenses authorized as of today. China Cord Blood Corporation
provides cord blood collection, laboratory testing, hematopoietic
stem cell processing and stem cell storage services. For more
information, please visit the Company's website at
http://www.chinacordbloodcorp.com.
Safe Harbor Statement
This press release contains forward-looking statements as
defined by the Private Securities Litigation Reform Act of 1995.
Forward-looking statements include statements concerning plans,
objectives, goals, strategies, future events, performance and
results of operations, and underlying assumptions and other
statements that are other than statements of historical facts.
These statements are subject to uncertainties and risks including,
but not limited to, product and service demand and acceptance,
changes in technology, economic conditions, the impact of
competition and pricing, government regulation, and other risks
contained in statements filed from time to time with the U.S.
Securities and Exchange Commission. All such forward-looking
statements, whether written or oral, and whether made by or on
behalf of the Company, are expressly qualified by the cautionary
statements and any other cautionary statements which may accompany
the forward-looking statements. In addition, the Company disclaims
any obligation to update any forward-looking statements to reflect
events or circumstances after the date hereof.
For more information, please contact:
China Cord Blood Corporation
Investor Relations Department
Tel: (+852) 3605-8180
Email: ir@chinacordbloodcorp.com
ICR, Inc.
Mr. William Zima
Tel: (+86) 10-6583-7511 (China) or
(+1) 646-405-5185 (U.S.)
Email: william.zima@icrinc.com
View original
content:http://www.prnewswire.com/news-releases/china-cord-blood-corporation-announces-results-of-extraordinary-general-meeting-of-shareholders-to-change-company-name-to-global-cord-blood-corporation-300615175.html
SOURCE China Cord Blood Corporation